Investor

News

 

July 2019 – Press release: 


STENOCARE to establish the world’s first hybrid, in-door cultivation facility for production of premium medical cannabis at scale

(225 Kb)
Press Release English

 

July 2019 – Press release: 


STENOCARE receives new information from CannTrust that causes immediate quarantine on sales of products from current inventory

(182 Kb)
Press Release English

 

July 2019 – Press release: 


STENOCARE UNHARMED BY HEALTH CANADA’S AUDIT OF CANNTRUST

(185 Kb)
Press Release English

 

July 2019 – Press release: 


STENOCARE enters the Irish market with its own subsidiary

(190 Kb)
Press Release English

 

June 2019 – Press release: 


STENOCARE A/S: Danish cannabis cultivation commenced

(182 Kb)
Press Release English

 

May 2019 – Press release: 

STENOCARE A/S is ready with new medical cannabis product 

(171 Kb)
Press Release English

 

May 2019 – Press release: 

STENOCARE A/S has been declared IPO of the Year 2018

(184 Kb)
Press Release English

 

May 2019 – Press release: 

Communique from the Annual General Meeting of STENOCARE A/S

(220 Kb)
Press Release English

 

May 2019 – Press release: 

STENOCARE publishes Interim Report First Quarter 2019

(221 Kb)
Press Release English

 

April 2019 – Press release: 

STENOCARE publishes Annual Report for the fiscal year 2017/2018

(186 Kb)
Press Release English

 

April 2019 – Press release: 

Shareholders in STENOCARE A/S nominate new member to the Board of Directors

(178 Kb)
Press release English

 

March 2019 – Press release: 

STENOCARE: Danish cannabis production due to start shortly

(173 Kb)
Press release English

 

March 2019 – Press release: 

STENOCARE products are being used in clinical trials at Rigshospitalet Multiple Sclerosis Center. The Danish Programme for medical cannabis has objectives to both enable patients to be treated with cannabis, and to learn about the effects of the treatment via clinical trials.
According to the Danish Ministry of Health more than 1400 patients have been treated with medical cannabis during the last 14 mths – which is a higher number than expected by the Ministry.

(163 Kb)
Press release English

 

February 2019 – Press release: 

STENOCARE A/S today published the Year-end report 2017/2018 including the fifth quarter 2018.

(201 Kb)
Press release English

 

February 2019 – Press release: 

STENOCARE A/S achieved its objective of delivering 2,100 treatments during September to December 2018

(200 Kb)
Press release English

 

December 2018 – Press release: 

STENOCARE A/S on track with the planned offering of Medical Cannabis Capsules to offer Danish patients more choice in their treatment

(198 Kb)
Press release English

 

November 2018 – Press release: 

STENOCARE A/S experiences positive demand and imports the second batch of medical cannabis oil products

(249 Kb)
Press release English

 

November 2018 – Press release: 

STENOCARE A/S Interim Report Fourth Quarter 2018

(191 Kb)
Press release English

 

November 2018 – Press release: 

STENOCARE A/S responds to requests from physicians and patients with initiative to expand the medical cannabis product portfolio with capsules

(196 Kb)
Press release English

 

October 2018 – Press release: 

GEMSTONE Capital decide to exercise 45000 warrants as described in the Memorandum

(214 Kb)
Press release English

 

October 2018 – Press release: First day (26.10.2018) of trading in STENOCARE A/S shares on Spotlight Stock Market

Today, October 26, 2018, is the first day of trading in STENOCARE A/S’s shares on Spotlight Stock Market.The share is traded under the ticker STENO.

(204 Kb)
Press release English
(204 Kb)
Press release Swedish

 

October 2018 – Press release:

STENOCARE A/S new share issue significantly oversubscribed. STENOCARE received subscribtion for a total of approx. DKK 402 million, including subscribtion commitments, from a total of 11.812 investors.

(221 Kb)
Press release English
(222 Kb)
Press release Swedish

 

September 2018 – Press release:  The subscription period in STENOCARE new share issue begins today (24.09.2018)

Today, September 24th, 2018, the subscription period in STENOCARE new share issue prior to planned listing on Spotlight Stock Market begins.  The subscription period ends on October 9th, 2018

(881 Kb)
Press release English
(872 Kb)
Press release Swedish


September 2018 - Press release: The first medical cannabis IPO in Europe has been approved for listing on Spotlight Stock Market (PDF doc)

(251 Kb)
Press release English
(264 Kb)
Press release Swedish

 

September 2018 – Press release: CannTrust Makes History with First Shipment of...

CannTrust Holdings, one of Canada’s leading and most trusted licensed producers of cannabis, today announced that it has completed its first shipment of cannabis oils to Danish Joint Venture Partner STENOCARE. With this groundbreaking shipment, CannTrust and STENOCARE are changing the face of medicine in Denmark by offering the first and only medical cannabis oils to be accepted onto the Danish Medicine List by the Danish Medicine Agency.

Read the full English press release HERE

 

July 2018 – Press release: The first medical cannabis oil products are coming

STENOCARE are the first in the Danish four-year Programme (Forsøgsordningen) to have their medical cannabis oil products approved for The Danish Medicine List, that is regulated by The Danish Medicine Agency.

Read the full Danish press release HERE

 

June 2018 – Article of STENOCARE medical cannabis product availability for Danish patients

Joint venture kickoff cannabis adventure in east Jutland: “We have been operating under the radar to be first-movers”.

The company has succeeded having their medical cannabis oil products approved for the Danish Medicine List – that is regulated by The Danish Medicine Agency.

Read the full Danish article HERE

 

March 2018 – Press release: The CannTrust – STENOCARE Partnership
CannTrust Holdings expands internationally through joint venture.

Initially CannTrust will ship products to STENOCARE with plans to develop and build a full cultivation and production facility in Denmark. CannTrust Holdings Inc, one of Canada’s leading licensed producers of cannabis, announced today that it has entered into a Joint Venture Agreement with STENOCARE, a company located in Denmark. STENOCARE is one of the first Danish companies to receive its license to grow and produce medical cannabis, as well as to import and sell cannabis products in Denmark.

Read the full English press release HERE

 

December 2017 – Press release: STENOCARE receive approval for cultivation and production from The Danish Medicine Agency.

Danish announcement: STENOCARE receive approval from The Danish Medicine Agency to cultivate and produce medical cannabis. The company is in the very first wave of licensed producers in Denmark and Europe.

Read the full Danish press release HERE